Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-13.36
Price to sales ratio
2.51

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2434
CSTL
Castle Biosciences, Inc. - Common stock
33.96 USD-0.88%+0.92%+41.91%+37.96%1.04 B USD
2537
ACRS
Aclaris Therapeutics, Inc. - Common Stock
6.02 USD-2.27%-6.81%+12.73%+225.41%886.14 M USD
3007
PRE
Prenetics Global Limited - Class A Ordinary Share
26.25 USD+1.82%+37.51%+43.84%+248.14%442.94 M USD
3326
MYGN
Myriad Genetics, Inc. - Common Stock
3.14 USD-1.26%-1.88%-41.09%-62.03%300.34 M USD

Frequently asked questions about Fulgent Genetics, Inc. Common Stock

What is the Fulgent Genetics, Inc. Common Stock stock price today?

The current price of Fulgent Genetics, Inc. Common Stock (FLGT) is 19.69. Over the past 24 hours, the stock has changed by -1.30%. Follow the FLGT chart for real-time price dynamics.

What is the stock ticker of Fulgent Genetics, Inc. Common Stock?

Fulgent Genetics, Inc. Common Stock trades under the ticker FLGT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Fulgent Genetics, Inc. Common Stock stock going up?

FLGT has changed by -0.86% over the last week, +1.03% over the last month, and -16.67% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Fulgent Genetics, Inc. Common Stock?

Fulgent Genetics, Inc. Common Stock currently has a market capitalization of 541.78 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Fulgent Genetics, Inc. Common Stock earnings last quarter?

Last quarter, Fulgent Genetics, Inc. Common Stock reported earnings of -1.05 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Fulgent Genetics, Inc. Common Stock revenue for the last quarter?

Fulgent Genetics, Inc. Common Stock reported quarterly revenue of 85.39 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Fulgent Genetics, Inc. Common Stock net income for the last quarter?

Fulgent Genetics, Inc. Common Stock reported net income of -29.53 M for the last quarter. The previous quarter showed -24.83 M, which means net income changed by -18.95%.

How many employees does Fulgent Genetics, Inc. Common Stock have?

As of the latest available data, Fulgent Genetics, Inc. Common Stock has 1 315 employees. Workforce size can provide additional context about the company's scale and operations.

What is Fulgent Genetics, Inc. Common Stock EBITDA?

Fulgent Genetics, Inc. Common Stock EBITDA is -28.4 M, and its EBITDA margin is -33.26%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Fulgent Genetics, Inc. Common Stock stock?

You can buy Fulgent Genetics, Inc. Common Stock (FLGT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Fulgent Genetics, Inc. Common Stock stock?

Investing in Fulgent Genetics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FLGT chart and related analysis on metatrader.com as part of your research.

News